Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1995-11-30
|
pubmed:abstractText |
Lipopolysaccharide (LPS) stimulation of the human monocytic cell line Mono Mac 6 leads to rapid expression of both the pro-inflammatory cytokine tumor necrosis factor (TNF) and the anti-inflammatory cytokine interleukin-10 (IL-10). Preculture of these cells with a low dose of LPS for 2 days rendered the cells tolerant to subsequent stimulation, in that TNF gene expression is only minimal, both at the mRNA and at the protein level. IL-10 shows a reciprocal pattern, however, as expression of this gene is upregulated in precultured cells, and it will further increase upon subsequent stimulation. Although TNF has been shown to induce IL-10, and IL-10 was found to downregulate TNF, this reciprocal regulation does not explain the pattern observed in LPS tolerance in Mono Mac 6, since neutralizing antibodies against TNF and IL-10 could not prevent upregulation of IL-10 and downregulation of TNF, respectively. Treatment of Mono Mac 6 cells during LPS preculture with interferon-gamma (IFN-gamma) could, however, reverse tolerance: LPS/IFN-gamma precultured cells produced high levels of TNF transcripts upon subsequent stimulation, while the response of the IL-10 gene was attenuated. The data show that LPS tolerance does not involve a passive downregulation of all types of monocyte functions, but it is an orchestrated response with downregulation of pro- and upregulation of anti-inflammatory cytokines.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD14,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-10,
http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1078-7852
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
56-63
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7583353-Antibodies,
pubmed-meshheading:7583353-Antigens, CD14,
pubmed-meshheading:7583353-Base Sequence,
pubmed-meshheading:7583353-Blotting, Northern,
pubmed-meshheading:7583353-Cell Line,
pubmed-meshheading:7583353-DNA Primers,
pubmed-meshheading:7583353-Drug Tolerance,
pubmed-meshheading:7583353-Gene Expression Regulation,
pubmed-meshheading:7583353-Humans,
pubmed-meshheading:7583353-Interleukin-10,
pubmed-meshheading:7583353-Lipopolysaccharides,
pubmed-meshheading:7583353-Macrophages,
pubmed-meshheading:7583353-Molecular Sequence Data,
pubmed-meshheading:7583353-Monocytes,
pubmed-meshheading:7583353-Polymerase Chain Reaction,
pubmed-meshheading:7583353-RNA, Messenger,
pubmed-meshheading:7583353-Tumor Necrosis Factor-alpha
|
pubmed:year |
1995
|
pubmed:articleTitle |
Interleukin-10 is upregulated in LPS tolerance.
|
pubmed:affiliation |
Institute for Immunology, University of Munich, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|